Dongsheng Duan
Affiliations: | University of Missouri - Columbia, Columbia, MO, United States |
Area:
Microbiology Biology, Virology Biology, Molecular BiologyGoogle:
"Dongsheng Duan"Children
Sign in to add trainee| Arkasubhra Ghosh | grad student | 2007 | University of Missouri - Columbia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rana J, Herzog RW, Muñoz-Melero M, et al. (2024) B cell focused transient immune suppression protocol for efficient AAV readministration to the liver. Molecular Therapy. Methods & Clinical Development. 32: 101216 |
| Shoti J, Qing K, Keeler GD, et al. (2023) Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy. Molecular Therapy. Methods & Clinical Development. 31: 101147 |
| Haffner V, Nourian Z, Boerman EM, et al. (2023) Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart. American Journal of Physiology. Heart and Circulatory Physiology |
| Duan D. (2023) Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond. Human Gene Therapy. 34: 345-349 |
| Kumar SRP, Duan D, Herzog R. (2023) Immune Responses to Muscle-Directed AAV Gene Transfer in Clinical Studies. Human Gene Therapy |
| Morales ED, Yue Y, Watkins TB, et al. (2023) Dwarf Open Reading Frame (DWORF) Gene Therapy Ameliorated Duchenne Muscular Dystrophy Cardiomyopathy in Aged mdx Mice. Journal of the American Heart Association. e027480 |
| Chamberlain J, Robb M, Braun S, et al. (2023) Micro-dystrophin expression as a surrogate endpoint for Duchenne muscular dystrophy clinical trials. Human Gene Therapy |
| Birch SM, Lawlor MW, Conlon TJ, et al. (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815 |
| Wasala N, Yue Y, Hu B, et al. (2022) Life-long outcomes of systemic AAV micro-dystrophin gene therapy in a murine Duchenne muscular dystrophy model. Human Gene Therapy |
| Hakim CH, Kumar SRP, Pérez-López D, et al. (2022) Assessment of the Gene Therapy Immune Response in the Canine Muscular Dystrophy Model. Methods in Molecular Biology (Clifton, N.J.). 2587: 353-375 |